Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine
- PMID: 624586
- PMCID: PMC414066
- DOI: 10.1128/iai.19.1.194-198.1978
Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine
Abstract
The ability of a killed phase I Coxiella burnetii vaccine to induce cell-mediated immune responses in guinea pigs was studied. Cell-mediated immune responses were assessed by the inhibition of macrophage migration and lymphocyte transformation assays. The macrophage migration response occurred rapidly and was detected at high levels, but was relatively short-lived. In contrast, the lymphocyte transformation response developed more slowly, and persisted for a longer period. The vaccine, given in a single dose or in two doses 1 week apart, protected guinea pigs from a subsequent virulent challenge.
Similar articles
-
Effect of lysozyme on the immune response of guinea pigs to the soluble phase 1 antigen of Coxiella burnetii.Acta Virol. 1981 Jul;25(4):241-4. Acta Virol. 1981. PMID: 6116419 No abstract available.
-
Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.Infect Immun. 1977 May;16(2):518-21. doi: 10.1128/iai.16.2.518-521.1977. Infect Immun. 1977. PMID: 324911 Free PMC article.
-
[Humoral immune response of goats, rabbits and guinea pigs following vaccination with a Q fever vaccine].Berl Munch Tierarztl Wochenschr. 1985 Jan 1;98(1):20-4. Berl Munch Tierarztl Wochenschr. 1985. PMID: 3985935 German. No abstract available.
-
Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.Ann N Y Acad Sci. 1992 Jun 16;653:88-111. doi: 10.1111/j.1749-6632.1992.tb19633.x. Ann N Y Acad Sci. 1992. PMID: 1626897 Review.
-
Immunity in Q fever.Acta Virol. 1988 Jul;32(4):358-68. Acta Virol. 1988. PMID: 2903642 Review.
Cited by
-
Q fever immunology: the quest for a safe and effective vaccine.NPJ Vaccines. 2023 Sep 7;8(1):133. doi: 10.1038/s41541-023-00727-6. NPJ Vaccines. 2023. PMID: 37679410 Free PMC article. Review.
-
Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.Infect Immun. 1993 Apr;61(4):1251-8. doi: 10.1128/iai.61.4.1251-1258.1993. Infect Immun. 1993. PMID: 8454328 Free PMC article. Clinical Trial.
-
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.Clin Exp Immunol. 1980 Aug;41(2):225-36. Clin Exp Immunol. 1980. PMID: 7438552 Free PMC article.
-
Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.Infect Immun. 1982 Mar;35(3):1091-102. doi: 10.1128/iai.35.3.1091-1102.1982. Infect Immun. 1982. PMID: 7068212 Free PMC article.
-
Q Fever Vaccine Development: Current Strategies and Future Considerations.Pathogens. 2021 Sep 22;10(10):1223. doi: 10.3390/pathogens10101223. Pathogens. 2021. PMID: 34684172 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources